Teladoc Health Partners With Eli Liily’s LillyDirect to Expand Access to Zepbound For Weight Loss

Telemedicine operator Teladoc Health Inc (NYSE:TDOC) has entered a pharmacy integration agreement with Eli Lilly And Co’s (NYSE:LLY) LillyDirect, a direct-to-consumer pharmacy partner, to streamline access to Zepbound (tirzepatide) for members of Teladoc’s Comprehensive Weight Care Program.

Last year, Eli Lilly announced a new website allowing patients to get a prescription for weight loss through a telehealth provider, marking an industry first.

The collaboration aims to provide affordable and safe options for individuals without insurance coverage for GLP-1 …

Full story available on Benzinga.com